Diagnostic Collaboration and Licensing Deals 2019-2024


Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2024

Publication date
May 2024
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

Diagnostic Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the diagnostic deals entered into by the worlds leading biopharma companies.

Fully revised and updated, the report provides details of diagnostic deals from 2019 to 2024.

The report provides a detailed understanding and analysis of how and why companies enter diagnostic deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. 

The report includes collaboration, development, research and licensing deals.

This report contains a comprehensive listing of 1640 diagnostic deals announced since 2019 including financial terms where available including links to online deal records of actual diagnostic partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of diagnostic dealmaking. 

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in diagnostic dealmaking since 2019.

Chapter 3 provides an overview of the leading diagnostic deals since 2019. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in diagnostic dealmaking with a brief summary followed by a comprehensive listing of diagnostic deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of diagnostic deals signed and announced since Jan 2019, where a contract document is available in the public domain. 

Chapter 6 provides a comprehensive and detailed review of diagnostic partnering deals signed and announced since Jan 2019. The chapter is organized by specific diagnostic technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in diagnostic deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Diagnostic Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse diagnostic collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Report scope

Diagnostic Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of diagnostic trends and structure of deals entered into by leading biopharma companies worldwide.

Diagnostic Collaboration and Licensing Deals includes:
•    Trends in diagnostic dealmaking in the biopharma industry
•    Directory of diagnostic deal records covering pharmaceutical and biotechnology
•    The leading diagnostic deals by value
•    Most active diagnostic licensing dealmakers

Diagnostic Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

•    What are the precise rights granted or optioned?
•    What is actually granted by the agreement to the partner company?
•    What exclusivity is granted?
•    What is the payment structure for the deal?
•    How are sales and payments audited?
•    What is the deal term?
•    How are the key terms of the agreement defined?
•    How are IPRs handled and owned?
•    Who is responsible for commercialization?
•    Who is responsible for development, supply, and manufacture?
•    How is confidentiality and publication managed?
•    How are disputes to be resolved?
•    Under what conditions can the deal be terminated?
•    What happens when there is a change of ownership?
•    What sublicensing and subcontracting provisions have been agreed?
•    Which boilerplate clauses does the company insist upon?
•    Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
•    Which jurisdiction does the company insist upon for agreement law?

Diagnostic Collaboration and Licensing Deals provides the reader with the following key benefits:

•    Understand deal trends since 2019
•    Browse diagnostic collaboration and licensing deals
•    Benchmark analysis – identify market value of transactions
•    Financials terms - upfront, milestone, royalties
•    Directory of deals by company A-Z, deal type and therapy area
•    Leading deals by value
•    Most active dealmakers
•    Identify assets and deal terms for each transaction
•    Access contract documents - insights into deal structures
•    Due diligence - assess suitability of your proposed deal terms for partner companies
•    Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in diagnostic dealmaking
2.1. Introduction
2.2. Diagnostic deals over the years
2.3. Most active diagnostic dealmakers
2.4. Diagnostic deals by deal type
2.5. Diagnostic deals by therapy area
2.6. Diagnostic deals by industry sector
2.7. Deal terms for diagnostic deals
2.7.1 Diagnostic deals headline values
2.7.2 Diagnostic deal upfront payments
2.7.3 Diagnostic deal milestone payments
2.7.4 Diagnostic royalty rates

Chapter 3 – Leading diagnostic deals
3.1. Introduction
3.2. Top diagnostic deals by value

Chapter 4 – Most active diagnostic dealmakers
4.1. Introduction
4.2. Most active diagnostic dealmakers
4.3. Most active diagnostic deals company profiles

Chapter 5 – Diagnostic contracts dealmaking directory
5.1. Introduction
5.2. Diagnostic contracts dealmaking directory

Chapter 6 – Diagnostic dealmaking by technology type

Deal directory

Deal directory – Diagnostic deals by company A-Z
Deal directory – Diagnostic deals by deal type
Deal directory – Diagnostic deals by therapy area

Deal type definitions

About Biopharma Research Ltd    
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Diagnostic deals since 2019
Figure 2: Active diagnostic dealmaking activity – 2019 - 2024
Figure 3: Diagnostic deals by deal type since 2019
Figure 4: Diagnostic deals by therapy area since 2019
Figure 5: Diagnostic deals by industry sector since 2019
Figure 6: Diagnostic deals with a headline value
Figure 7: Diagnostic deals with an upfront value
Figure 8: Diagnostic deals with a milestone value
Figure 9: Diagnostic deals with a royalty rate value
Figure 10: Top diagnostic deals by value since 2019
Figure 11: Most active diagnostic dealmakers 2019 - 2024
Figure 12: Diagnostic deals by technology type since 2019

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted PDF)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

2cureX, 3a-diagnostics, 3B Pharmaceuticals, 3Derm Systems, 3M, 4bases, 4D Molecular Therapeutics, 4D Path, 23andMe, 221b Foundation, 1717 Life Science Ventures, A2 Biotherapeutics, A3P Biomedical, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, Abingdon Health, Abionic, Abramson Cancer Center, ABX, ABX-CRO Advanced Pharmaceutical Services, Academic Breast Cancer Consortium, Accelerate Diagnostics, Accelerate Technologies, Accudata Systems, AccuLine, Accurate Diagnostic Laboratories, AccuStem Sciences, AchilleS Vaccines, Acibadem University, ACIST Medical Systems, Acrivon Therapeutics, ACROBiosystems, Actelion, Actome, Acumen Diagnostics, Acutus Medical, AdAlta, Adaptive Biotechnologies, AdaptivEndo, Adaptive Phage Therapeutics, Adaptive Research, ADC Therapeutics, Adeptrix, Adial Pharmaceuticals, Adiso Therapeutics, Aditx Therapeutics, ADT Altona Diagnostic Technologies, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced Human Imaging, Advanced Nuclear Medicine Ingredients, Aegea Biotechnologies, AEterna Zentaris, AEYE Health, Afero, Africa Centres for Disease Control and Prevention, Africa Medical Supplies Platform, Africa Union, AgaMatrix, Age Labs, Agena Bioscience, Agendia, Agilent Technologies, Agiomix FZ, Agios Pharmaceuticals, Aidence, Aidoc, Aiforia Technologies, AIG Hospitals, AIMA Laboratories, AI Medical Service, Akoya Biosciences, Akribis Systems, Alamar Biosciences, Alberta Health Services, Albert Einstein College of Medicine, ALBOT Technologies, Alector, Aleris, Alexion Pharmaceuticals, Alfasigma, Algenex, Alibaba Health, Alimentiv, AliveCor, Allarity Therapeutics, Allegheny Technologies, Allelica, AllerGenis, Allogene Therapeutics, AllStripes, Allumiqs, Almac Diagnostics, Alnylam Pharmaceuticals, Alpenglow Biosciences, Alphageneron Pharmaceuticals, Alphazyme, AltaML, Altoida, Alume Biosciences, Alveo Technologies, Alverno Clinical Laboratories, Alzheimer's Drug Discovery Foundation, Alzheon, Amag Pharmaceuticals, Amazon Web Services, Ambergen, Ambra Health, Ambry Genetics, A Menarini Diagnostics, American College of Cardiology, American College of Chest Physicians, American Health Imaging, American Type Culture Collection (ATCC), Amgen, Amoy Diagnostics, AMRA Medical, AMS, Amydis, Analog Devices, AnchorDx, Andor Technology, Angle, AnHeart Therapeutics, Anixa Biosciences, Anpac Bio-Medical Science, Anteo Diagnostics, AnteoTech, Anthem, Antisoma Therapeutics, Anumana, Apollomics, Apollon Formularies, Applied DNA Sciences, APRINOIA Therapeutics, Aptagen, Aptamer Therapeutics, Aptitude Medical Systems, Aptorum Group, Arbor Biosciences, ArcDia, ArcherDX, ARCHIMEDlife, Ares Genetics, Arisan Therapeutics, Arizona State University, Arlington Scientific, Armed Forces Medical Research Institute, AroCell, ArteraAI, Artidis, Artificial, Artios Pharma, ARTMS Product, ARUP Laboratories, Arvinas, Asahi Kasei, Ascensia Diabetes Care, Asep Medical, ASG Superconductors, Ashion Analytics, Ashvattha Therapeutics, Asieris MediTech, Asieris Pharmaceuticals, Aslan Pharma, Aspen Imaging Healthcare, Assistance Publique-Hôpitaux de Paris, AssisTek, Astek Diagnostics, Astellas Pharma, Asthma UK, AstraZeneca, Astrin Biosciences, Asuragen, Athinoula A Martinos Center for Biomedical Imaging, Athletic Heart Cardiac and Metabolic Testing, Atila BioSystems, Atlas Antibodies, Atrin Pharmaceuticals, Attana, Autism Learning Partners, Autonomous Medical Devices Incorporated, Avacta, Avalon GloboCare, AvantGen, Avera Health, Avero Diagnostics, Avicenna Technology, Avinger, AVRA Surgical, Avrobio, AXIM Biotechnologies, Babson Diagnostics, Baebies, BAMF Health, BASF, Battelle, Baxter International, Bayer, Baylor College of Medicine, Baylor Scott and White Research Institute, BBI Solutions, BC Cancer Agency, BC Neuroimmunology, BC Platforms, BEAM Diagnostics, Beckman Coulter, Becton Dickinson, BeiGene, Beijing Genomics Institute (BGI), Belle.ai, Beroni Group, Berry Oncology, Beth Israel Deaconess Medical Center, Bethyl Laboratories, BGN Technologies, Bicycle Therapeutics, Big Eye Diagnostics, Biim Ultrasound, Bill and Melinda Gates Foundation, BillionToOne, Binx Health, Bio-Me, Bio-Rad Laboratories, Bio-Techne, bioAffinity Technologies, BioAge Labs, BioAgilytix, BIOASTER, BioCanna Healthcare, Biocare Medical, Biocartis, Biocept, BioCheetah, BioClinica, Biocodices, BioCopy, Biodesix, BioExcel Diagnostics, Biofidelity, BioFluidica, Biofourmis, BioGemex, Biogen, Biogenar, BioGen Medical, Biognosys, BioGX, BioInvent, BioIQ, Biokit, BioLight, BioLinQ, BioLizard, Biological Dynamics, BioMark Diagnostics, BioMarker Strategies, Biomedical Advanced Research and Development Authority, Biomedix, BioMed X Innovation Center, Biomeme, Biomerica, bioMerieux, BiomX, BioNano Genomics, BioNTech, Biora Therapeutics, Bioscience Pharma Partners, Biosearch Technologies, BioSkryb, BioSure, BioSymetrics, BioSyntagma, Biotage, Biotronik, BioVolume, Bird Foundation, Blackford, Blu Biotech, Blue Earth Diagnostics, Bluejay Diagnostics, Blueprint Genetics, Boehringer Ingelheim, Boehringer Ingelheim Vetmedica, Bosch, BostonGene, Boston Medical Center, Boston Scientific, Boston University, Bot Image, BPGbio, Bpifrance, Bracco Imaging, Brainomix, Brazlex Medical Genetics, Breath Diagnostics, BreathTech, Bredis Healthcare, Brenus Pharma, BriaCell Therapeutics, BrickBio, Brigham and Women's Hospital, BrightInsight, Bristol-Myers Squibb, Broad Institute, Broncus Technologies, Brotman-Baty Institute, Bruker, Burkhan Group, Burning Rock, BurstIQ, Butterfly Network, BYG4lab, C2i Genomics, C2N Diagnostics, C2Sense, Calviri, Calyx, Cambridge Consultants, Cambridge Enterprise, Canadian Armed Forces, Canadian Cancer Society, Canadian Institutes of Health Research, Canary Health Technologies, Cancer Research UK, CancerX initiative, Canon, Canon BioMedical, Cantabio Pharmaceuticals, Cantel Medical, Capitainer, Capsulomics, Caption Health, CARB-X, Cardea Bio, Cardiff University, Cardiomatics, CareDx, Caris Life Sciences, Carl Zeiss, Cartana, Case Western Reserve University, Castle Biosciences, Catabasis Pharmaceuticals, CathWorks, CBD Solutions, CeGaT, Celcuity, Celdara Medical, Celgene, Cellgen Diagnostics, Cell Guidance Systems, CellMax Life, Cell Microsystems, Cellpath, CellSafe, Celsius Therapeutics, Cenetron, Censis Technologies, Centene, Centers for Disease Control and Prevention, Centogene, Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Cepheid, CereHealth, Ceres Nanosciences, Cerevast Therapeutics, CERIMED, Cernostics, CerTest Biotec, Certis Oncology Solutions, Cerveau Technologies, CgBio, Champalimaud Foundation, Champions Oncology, Charcot-Marie-Tooth Association, Charite Universitatsmedizin Berlin, Charles River Laboratories, Chembio Diagnostics, Children's Hospital Boston, Children's Hospital of Philadelphia, China Biotech Services, China Grand Pharma, China Grand Pharmaceutical, Chinook Therapeutics, ChromaCode, Chronix Biomedical, Chronolife, Chubu University, Chugai Pharmaceutical, Cicero Diagnostics, CIC Health, Cipla, Circle cardiovascular imaging, Cirrus Dx, Cizzle Biotech, CK Life Sciences, Clario, ClariPi, Claritas HealthTech, Clarity Pharmaceuticals, Clarius Mobile Health, Clarix, Cleared4, Clear Medical Imaging, ClearNote Health, ClearPoint Neuro, Clearsky Medical Diagnostics, Cleveland Clinic, Cleveland University Hospitals, Client Outlook, Clinical Enterprise, Clinical Laserthermia Systems (CLS), Clinton Health Access Initiative, Clovis Oncology, CLX Health, CND Life Sciences, Co-Diagnostics, Coala Life, Codexis, Coeptis Pharmaceuticals, Cofactor Genomics, Cognoa, CogState, Colorado Melanoma Foundation, Columbia University, Columbia University Medical Center, Companion Medical, ConcertAI, Concert Genetics, Cone Health, Confo Therapeutics, Congenica, Consilient Health, Cooper Companies, CoreBiome, CorePath Laboratories, CorePlus, Cornell University, Cortechs.ai, CorTechs Labs, Corteva Agriscience, Corvium, Cosmo Pharmaceuticals, Covance, CPT Medical, CQuentia, Cradle Genomics, CrestOptics, CrisprBits, Criterium, Crohn's and Colitis Foundation of America, Crosscope, CStone Pharmaceuticals, Cue Health, Culmination Bio, Cumming, Curasight, Curative, CureMetrix, Curetis, Curium, Curta, Cyclerion Therapeutics, Cypre, Cytiva, Cytogen, CytoVale, Cytox, D&K Engineering, Daiichi Sankyo, Dana-Farber Cancer Institute, Dartmouth-Hitchcock Medical Center, DaRui Biotech, DarwinHealth, DATANet Software Development, Data Tecnica International, Day One Biopharmaceuticals, Day Zero Diagnostics, DCN Diagnostics, Debiopharm, Decipher Biosciences, Deciphex, deCODE Genetics, Deep Bio, Deepcell, Deep Cube, DeepVerge, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Definiens, Dell Medical School, Delphi Diagnostics, DemDx, Dendreon, Denovo Biopharma, Densitas, Denso, Department of Defense, Department of Health and Human Services, DePuy, Detect-Ion, Devyser Diagnostics, DexCom, DiaCarta, Diaceutics, Diadem, Diagnostic Biochips, DiA Imaging Analysis, DiamiR, DIAN Diagnostics, Diannei Biotechnology, Diaprost, DiaSorin, Diaspective Vision, Diatech Pharmacogenetics, Diesse Diagnostica Senese, Digital Diagnostics, Digostics, Diomics, Diversigen, DNAnexus, DoMore Diagnostics, Domus Diagnostics, Draeger Safety Diagnostics, Draper Laboratories, Drawbridge Health, DreaMed Diabetes, DuChemBio, Duchenne UK, Duke University, Dxcover, DxVx, DynamiCure Biotechnology, DYNEX Technologies, E25Bio, Early is Good, EC Healthcare, EchelonDx, EchoNous, Echosens, Eckert & Ziegler, Ecolog International, Edan Instruments, EDP Biotech, EDX Medical, Efferent Labs, eGenesis, Eisai, Eko, Elephas, Elevation Oncology, Eli Lilly, Ellume, ELNA Medical, Emergency Medicine Foundation, EmeritusDX, Emit Imaging, Emory University, Empatica, Empowered Diagnostics, Enable Biosciences, Enable Medicine, Endocanna Health, Endoluxe, EndoSound, Enigma Biomedical, Envista, Enzo Biochem, Enzyre, Epic, EpicGenetics, Epic Sciences, Epiphany Dermatology, Epivax, Epsilon, Erasmus University Medical Center, ERT, ESSA Pharma, Essen University Hospital, Ethos Laboratories, Ethos Research & Development, Euformatics, Eureka Eurostars, Eurobio, Eurocine Vaccines, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Innovation Council, European Institute of Oncology (EIO), European Prevention Center, European Union, EV Biologics, EverlyWell, Evogen, Evotec, Evvy, Exact Sciences, Exagen Diagnostics, Exai Bio, Excella, Exigent Research, EXINI Diagnostics, Exo, Exosome, Exosome Diagnostics, Exosome Sciences, Expedeon, Expesicor, ExSeed, F-Star Therapeutics, Fabric Genomics, Factorial Diagnostics, Faes Farma, Falco, Fapon Biopharma, Farcast Biosciences, Federal Ministry of Education and Research (BMBF), Ferring Pharmaceuticals, Ferronova, Ferrum Health, FibriCheck, Fibrogen, Finnish Institute for Health and Welfare, Fio, First Genetics JCS, FitBit, FivepHusion, FK LiveLabs, Flagship Biosciences, Flare Therapeutics, Flatiron Health, Florida Atlantic University Research, Florida Theranostics, FlowMetric, Fluidigm, Fluxergy, Fluxion Biosciences, Flywheel, Focal Healthcare, Food and Drug Administration (FDA), Foresight Diagnostics, Fortelinea Software Systems, Fortis Therapeutics, Foundation for Innovative New Diagnostics, Foundation Medicine, Fox Chase Cancer Center, Francis Crick Institute, Fraunhofer Institute for Cell Therapy and Immunology, Freenome, Fresenius, Friends of Cancer Research, Fujifilm, Fujifilm Irvine Scientific, Fujifilm medical systems, FUJIFILM SonoSite, Fujirebio Diagnostics, Fulcrum Therapeutics, Fulgent Genetics, Functional Gut Diagnostics, Fundacion Progreso y Salud, Fusion Genomics, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, FYR Diagnostics, G42 Healthcare, Galectin Therapeutics, GANZIMMUN Diagnostics, GBS, GC Genome, GE Healthcare, Gemini Therapeutics, Gencove, Gene Bio Medical, GeneCentric Therapeutics, GeneDX, Genentech, Geneoscopy, GeneQuantum Healthcare, General Graphene, Geneseeq, GenesisCare, GeneThera, Genetic Alliance, Genetic Technologies, Genetron Health, Geneva University Hospitals, Genfit, Gennova Biopharmaceuticals, Genolution, Genomadix, Genome Canada, Genome Diagnostics, Genome Quebec, Genomic Prediction, Genomic Testing Cooperative, Genomill Health, Genomoncology, GenoScreen, Genosity, GenScript Biotech, GensKey Medical Technology, Gentex, Georgetown University, George Washington University, German Cancer Research Center, German Federal Ministry of Education and Research, Gestalt Diagnostics, Getein Biotech, Gibson Oncology, Ginkgo BioWorks, GI OnDEMAND, GI Reviewers, Global Access Diagnostics, Global Dx, Global Health Labs, Global Lung Cancer Coalition, Global Virus Network, Global WholeHealth Partners, GlucoModicum, Glytec, GNA Biosolutions, GNS Healthcare, Google, GoPath Diagnostics, Government of South Korea, Gradient Health, Grail, Granville Biomedical, GrapheneDx, Greenfield Global, Gritstone Bio, Group K Diagnostics, Growshapes, GSK, GSK Consumer Healthcare, GT Molecular, Guardant Health, Guardian Research Network, Guerbet, Guided Therapeutics, Gusto Global, Gyros Protein Technologies, Hackensack Meridian Health, Hadassah Medical Center, Hai Kang Life, Hainan Sinotau Pharmaceutical, Halodoc, Halo Dx, HALO Precision Diagnostics, Hamamatsu Photonics, Hamilton Company, Hamilton Robotics, Harbinger Health, Harvard Medical School, Harvard University, Haystack Oncology, Healint, Healium Medical, HealPros, HealthCare Konnect, Healthimation, Health Logic Interactive, Health Network Laboratories, Health Recovery Solutions, Healthy.io, HeartBeam, Heartflow, HeartSciences, Heat Biologics, Helio Genomics, Helio Health, Helix, Hememics Biotechnologies, Hemex Health, Henan Cancer Hospital, Hengrui Therapeutics, Henlius Biotech, Henry Ford Health System, Henry M. Jackson Foundation, HepQuant, Hereditary Neuropathy Foundation, Hermes Medical Solutions, Heska, HiberCell, High Desert Heart Institute, HiloProbe, HistoCyte Laboratories, HistoIndex, Hitachi, Hoag Memorial Hospital Presbyterian, Holberg EEG, Holobeam Technologies, Hologic, Hoowaki, Horizon Therapeutics, Hospital Clinic of Barcelona, Hospital Fondation Adolphe de Rothschild, Hospital for Special Surgery, Hoth Therapeutics, HotSpot Therapeutics, HOYA Corporation, HP, HTG Molecular Diagnostics, Huami, Hubrecht Organoid Technology, Huma, Hummingbird Bioscience, Huntsman Cancer Institute, Hvidovre Hospital, Hyperfine Research, I-mab, IBA, Ibex Medical Analytics, IBM, IBM Watson Health, iCAD, Icahn School of Medicine at Mount Sinai, ICAN, Icometrix, Idaho Urologic Institute, IDbyDNA, IdentifySensors Biologics, ii Ventures, Ikonisys, Ikonopedia, Illumina, ImaBiotech, Image Analysis, ImageBiopsy Lab, ImageMover, ImaginAb, Imaging Endpoints, Imago Systems, Imaware, IMBdx, Imbio, Imec, Imeka, ImmersiveTouch, Immucor, Immunexpress, ImmunoPrecise Antibodies, Immunovia, IMPACT Therapeutics, Imperial College London, Imricor Medical Systems, Inagene Diagnostics, INanoBio, Inari Medical, IncellDx, Incyte, Indiana University, Indica Labs, Indivumed, Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, Infectolab Americas, Infervision, Infinitt, Infinity BiologiX, Inflammatix, Inflammatory Breast Cancer Research Foundation, Inflazome, Inform Diagnostics, InformedDNA, InfYnity Biomarkers, inHEART, Inivata, Innodem Neurosciences, Innoplexus, Innosuisse, InnoTech Precision Medicine, Innovate BC, Innovate UK, Innovation Zed, Innovative Health Diagnostics, Innovo, Inotrem, Inovio Pharmaceuticals, Inozyme Pharma, Inscopix, InSightec, InSphero, Institut Curie, Institute for Bioscience and Biotechnology Research, Institute for Systems Biology, Institute of Organic Chemistry and Biochemistry, Institute of Virology and Immunology, Institut Gustave Roussy, Institut Paoli-Calmettes, Institut Pasteur, Insulet, Integrated Computer Solutions, Integrated Micro-Chromatography Systems, Intel, Intelligent Scopes, Intermountain Healthcare, International Association for the Study of Lung Cancer, International Centers for Precision Oncology Foundation, International Isotopes, IntroMedic, Invenio Imaging, inviCRO, Invitae, InVivoScribe, Ionetix, Ionian University, iQ Group, iRhythm Technology, IRIS, IRIS International, iSchemaView, Isotopia Molecular Imaging, Iterative Scopes, iThera Medical, ITM Isotopen Technologien, ITOCO, IV BioHoldings, IXICO, JADBio, Jain Foundation, Jana Care, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Japan Agency for Medical Research and Development, Jefferson Healthcare, Jeffrey Modell Foundation, Jiangsu Chia Tai Tianqing Pharmaceutical, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medicine (JHM), Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Johnson & Johnson Innovation, John Wayne Cancer Institute, Joslin Diabetes Center, Jubilant Radiopharma, Juntendo University, Kanazawa University, Kansas University Medical Center (KUMC), Kantaro Biosciences, Karius, Karolinska Institute, Karolinska University Hospital, Kartos Therapeutics, Karyopharm Therapeutics, KDx Diagnostics, Keio Gijuku University, KELTIC Pharma, Kephera Diagnostics, Kettering Health, Key Technologies, Kheiron Medical Technologies, Kings College London, Kite Pharma, Kiyatec, KK Women’s and Children’s Hospital, Konica Minolta, Konica Minolta Precision Medicine, Kore, Korea Pharma, Kronos Bio, Krystal Biotech, Kubota Vision, L1 Systems, Laboratory Corporation of America, Labrador Technologies, La Jolla Institute for Allergy & Immunology, LamdaGen, Lantern Pharma, Lantheus Holding, Lantheus Medical Imaging, Lark Technologies, Latvian Institute of Organic Synthesis, Laurel Bridge Software, Lawson Health Research Institute, Leap Therapeutics, Leica Biosystems, Leica Microsystems, Leinco Technologies, Les Laboratoires Servier, Leucid Bio, Lexent Bio, LEXEO Therapeutics, LGC, Life Diagnostics, Life Genomics AB, Life Image, LifeLabs Medical Laboratory Services, LifeOmic, Life Raft Group, LifeSensors, LifeTech Scientific, LightDeck Therapeutics, Lightpoint Medical, Lightsense Technology, Li Ka Shing Foundation, LineaRx, Lipidomics Consulting, Liquid Biosciences, Little Warrior Foundation, Liverpool School of Tropical Medicine, Livongo Health, LogicInk, Longhorn Vaccines and Diagnostics, Lonza, Lucence, Luciole Medical, Lucira Health, Luminex, LuminUltra, Lumiphore, LumiraDx, Lunaphore, Lung Cancer Initiative, Lunit, Lupus Research Alliance, Lurie Children's Hospital of Chicago, Luxel, Macrogen, MagCorp, Magellan Healthcare, Magic Leap, Magle Chemoswed, Magnetic Insight, Magnetrap, Mainz Biomed, Mammoth Biosciences, Mannin Research, MapKure, Marubeni, Masimo, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Mauna Kea Technologies, MAVIDx, Maxim Biomedical, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, Mayo Clinic BioPharma Diagnostics, MBio Diagnostics, McGill University, McMaster University, MD Anderson Cancer Center, MD Biosciences, MDxHealth, MedAxiom, MedBridge, Medcase, Medexus Pharmaceuticals, Medgenics, Medial EarlySign, MEDIAN Technologies, Medical Marijuana, Medical University of Vienna, Medicinal Genomics, Medicover, Medidata Solutions, Medigus, Medipath, Medis, Meditemi, Medosome Biotec, Medovate, Medpace, MedQuest, Medtronic, Meenta, Meihua International Medical Technologies, Meilleur Technologies, Melanoma Research Alliance, MeMed, Memorial Hermann Health System, Memorial Sloan Kettering Cancer Center, Menon Biosensors, Merck and Co, Merck KGaA, Merge Healthcare, Meridian Bioscience, Mesa Biotech, Mesh Bio, Metabolomic Diagnostics, Metabolon, Metafora Biosystems, Methapharm, MGI Tech, Michael J Fox Foundation, Michelson Center, Michigan State University, Microbix Biosystems, MicroGEM, MicroGenDX, Microsoft, miDiagnostics, Milburn Foundation, Milu Labs, Mimetas, MindPeak, Minerva Imaging, Minnesota Health System, MIP Discovery, Mirati Therapeutics, Mirimus, miR Scientific, MiRXES, Mission Bio, MiTest Health, MITRO Biotech, MOBILion Systems, Mobility Health, Modalis Therapeutics, Moderna, Molbio Diagnostics, Molecular Biology Systems, Molecular Health, Molecular Instruments, Molecular Loop, Molecular Targeting Technologies, MolecuLight, MolGen, Mologic, Monoceros Biosystems, Montreal Neurological Institute-Hospital, Moss Genomics, Motus GI Medical Technologies, Mount Sinai Health System, MP Group, mProbe Laboratories, MRIGlobal, MRM Proteomics, MSD, Multi G, Multimmune, MultiOmic Health, Multiplex Genomics, Munich Technical University, Muscular Dystrophy Association, MyHealthChecked, Mylab Discovery Solutions, Myriad Genetics, Nano-X Imaging, NanoDx, NanoMab Technology, Nanomix, Nanommune, NanoMosaic, NanoPin Technologies, NanoSpot.ai, Nanostics Precision Health, NanoString Technologies, Narayana Nethralaya Foundation, NASA, Natera, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Cancer Institute of Mexico, National Center for Advancing Translational Sciences (NCATS), National Healthcare Services (NHS), National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institutes of Health, National Institutes of Health Clinical Center, National Kidney Foundation, National Organization for Rare Disorders, National Research Council Canada, National Science Foundation, National University of Ireland, Galway (NUI Galway), National Yang-Ming University, Natural Sciences and  Engineering Research Council of Canada, Natus Medical, Naval Medical Research Center, Naveris, Navidea Biopharmaceuticals, Navigate BioPharma Services, Navigate Surgical Technologies, Navignostics, Navy Medical Research Centre, NDR Medical Technology, NEC, Nektar Therapeutics, Nemaura Medical, NeoDynamics, Neogap Therapeutics, Neogen, Neogenomics, Neosoma, Nephron Pharmaceuticals, NeraCare, NervGen Pharma, NE Scientific, NeuMoDx Molecular, Neuro42, Neuro Bio, NeuroLogica, NeuroMetrix, Neuron23, NeuroNexus, NeuroOne, NeuroScience Associates, NeuroSense Therapeutics, Neurotrack, NeuSoft Medical Technologies, Neuvogen, New England Complex Systems Institute, New Horizon Health, New Jersey Urology, Newly Institute, NewStem, New York Blood Center, NexOptic, NextGate, Next Generation Manufacturing Canada, Nexus Medical, NGeneBio, Nico, Nicoya, Nikon Corporation, Nikon Instruments, Nima, Nimble Therapeutics, Nippon Kayaku, NOCD, Nonacus, Norgine, Noria Therapeutics, Northeastern University, Northern Light Health, NorthStar Medical Radioisotopes, Northwestern Medicine Bluhm Cardiovascular Institute, Northwestern University, Norwegian Institute of Public Health, Norwegian Research Council, Noscendo, NovAliX, Novarad, Novartis, NovaScan, Novel Microdevices, Novigenix, Novogene, Novo Nordisk, Novosound, NOWDiagnostics, NRG Oncology, nRichDX, NTT Data, Nuance Healthcare, Nucleai, Nucleix, Nuclidium, Numares, NuProbe, Nusano, Nuvo Group, NVDIA Corporation, Nvidia, nView Medical, NX Development, NX Prenatal, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, NZ Technologies, ObjectiveHealth, Ochin, Octant, Offspring Biosciences, Ohio State Innovation Foundation, Ohio State University, Oklahoma Medical Research Foundation, Olink Proteomics, Olive Labs, OLM Diagnostics, Olympus, OmeCare, Omega Diagnostics Group, Omega Laboratories, OmiCure, OmniPathology, OmniVision Technologies, Oncidium Foundation, Oncimmune, OncoAssure, OncoCyte, Oncoheroes Biosciences, OncoHost, Oncology Venture, OncoNano Medicine, Oncovet, OncXerna Therapeutics, Onera Health, OnLume Surgical, Ono Pharmaceutical, Onsite Women’s Health, Ontario Institute for Cancer Research, Ontera, Opentrons Labworks, OphtAI, Optellum, Optina Diagnostics, Optithera, Opto-Systems, Optomed, OracleBio, OraSure Technologies, Oregon Health Sciences University, OrigiMed, Orpheus Medical, Ortho-Clinical Diagnostics, OrthoGrid Systems, Osaka University, OSE Immunotherapeutics, Oslo University Hospital, Ospedale Pediatrico Bambino Gesu, Osteolabs, Othair Prothena, Ovation, oVio Technologies, OvuSense, Owkin, Owlstone Medical, Oxford Immunotec, Oxford Nanopore Technologies, Oxgene, Pacific Biosciences, Pacific Dental Services, PAI, Paige, Panaxium, Pancreatic Cancer Early Detection Consortium, Pan Probe Biotech, Paracelsus Clinics, Parent Project Muscular Dystrophy, Parexel, Parkway Clinical Laboratories, Partek, Parthenon Therapeutics, Passage Bio, PathAI, Pathan, PathGroup, Pathnova Laboratories, PathPresenter, PathSensors, Patia, Paul Scherrer Institute, PAVmed, Pennsylvania State University, PentixaPharm, Penumbra, Pepscan, PeptiDream, PerkinElmer, Personal Genome Diagnostics, Personalis, Perspectum Diagnostics, Pfizer, Pfizer Canada, PharmaCare Management, PharmaCyte Biotech, PharmaLogic, Phase Genomics, PHC, Phenomix, PhenoVista Biosciences, Philips, Phillips-Medisize, Philochem, Phoenix Molecular Designs, Phosphorus Genomics, Photocure ASA, PhysIQ, Phytronix Technologies, PierianDx, Pierre Fabre, Pillar Biosciences, Ping An Ventures, Pinpoint Science, Pionyr Immunotherapeutics, Pirche, Piur Imaging, PixCell Medical, Planmeca, Planmed, Plexision, Plus Therapeutics, Point32Health, POINT Biopharma, Polarean Imaging, Positron, PRA Health Sciences, Prairie Hub for Pandemic Preparedness, Precipio Diagnostics, PreciseDx, Precision Biomonitoring, Precision Diabetes, Precision for Medicine, PrecisionLife, Precision Pathology Services, Predicine, PredictImmune, Predictive Technology Group, Predictmedix, PrediLife, Premier Inc, PreMIT, Prenetics, Prenosis, Prescient Medical, Prevencio, Previse, Primary Bio, Princeton BioMeditech, PrinterPrezz, ProciseDx, Profusa, Progenics Pharmaceuticals, Progentec Diagnostics, Prolytix, Promaxo, Promega, Prometheus Biosciences, ProMIS Neurosciences, ProPath, Prophase Labs, Proprio, Proscia, Protean BioDiagnostics, Proteic Bioscience, ProteinLogic, ProteoMediX, ProterixBio, Protxx, Providence Saint John's Health Center, Provision Diagnostic Imaging, Provista Diagnostics, PSI CRO, Psyche Systems, PTC Therapeutics, PT Elion Medika, Public Health England, Puerto Rico Government, Puma Biotechnology, Purdue Research Foundation, PWNHealth, Q-linea AB, Q2 Solutions, Qiagen, Qlarity Imaging, QMC HealthID, QT Imaging, Qualigen, Quansys Biosciences, QuantalX Neuroscience, Quanterix, Quantinm, QuantumDx, Quantum Leap Health Care Collaborative, Quebec Heart and Lung Institute, Queens University Belfast, Quest Diagnostics, Quibim, Quidel, QuidelOrtho, Quotient, Qure.ai, Qure Healthcare, R-Pharm, Rabin Medical Center (Beilinson Hospital), Race Oncology, RadImageNet, Radiomedix, Radiopharm Theranostics, Radius Health, RadNet, Rady Children's Institute for Genomic Medicine, Ragon Institute, RapidAI, Rapid Dx Laboratory, Rarecells, RareCyte, Ratio Therapeutics, RayBiotech, Readout Health, Realm IDx, Redox, RefleXion Medical, Rejuve.AI, Relay Medical, Relay Therapeutics, Remidio Innovative Solutions, RenalytixAI, Renegade Bio, Renji Hospital, Renown Institute for Health Innovation, Repertoire Genesis, Resolution Bioscience, Resolve Biosciences, RespirAI Medical, RetinAI Medical, RetiSpec, RevealDx, Reveal Genomics, Revive Therapeutics, Rhinostics, RIGHT Foundation, Rigshospitalet, RIKEN Research Institute, Rimidi, Riverain Medical, RNA Disease Diagnostics, Roche, Roche Diagnostics, Rokline Health Concepts, Romer Labs, Rose F Kennedy Intellectual and Developmental Disabilities Research Center, Roswell Biotechnologies, Roswell Park Cancer Institute, ROTOP Pharmaka, Rouumtech, Royal College of Surgeons (Ireland), Royal Philips Electronics, RTI International, Rubix LS, Rutgers Cancer Institute of New Jersey, Rutgers University, RxCap, SAGA Diagnostics, Saitama Medical University Hospital, Saladax Biomedical, Salveo Diagnostics, Samsung Electronics, Sana Klinikum Offenbach, Sanford Health, Sano Genetics, Sansure Biotech, Saol Therapeutics, Sapphiros, Sarah Cannon Research Institute, Sarepta Therapeutics, Satio, Satisfai Health, Scailyte, Scandion Oncology, Scanwell Health, Scentian Bio, SciBase, Science 37, SCIMAGE, Scintomics, Scipher Medicine, Scivita Medical Technology, Scopio Labs, Screenpoint Medical, Seaspring, Seattle Children's Hospital, Seattle Childrens Research Institute, Sebela Pharmaceuticals, Sebia, Secarna Pharmaceuticals, SecondWave Systems, Sectra, See-Mode Technologies, Seegene, SeekIn, Segmed, Sema4, Semmelweis University, Sengenics, SEngine Precision Medicine, Senseonics, Sensible Medical Innovations, Sensifree, Sentinel Diagnostics, Sepset Biosciences, Serosep, Severn Safety Supply, Shandong Yingsheng Biotechnology, Shanghai Accurature Diagnostics, Shared Medical Services, Sheba Medical Center, Shenzhen Chipscreen Biosciences, Sherlock Biosciences, Shimadzu, Shire Human Genetic Therapies, Shuttle Pharmaceuticals, Shuwen Biotech, Sickle Cell 101, Siemens Healthineers, Signet Medical Solutions, SimBioSys, Simon Fraser University, SimonMed Imaging, Simsen Diagnostics, Sino Biological, Sinomed, Siolta Therapeutics, Sirona Dx, Sirona Medical, Sirtex Medical, Skane University Hospital, Skyline Diagnostics, SkylineDX, Skysong Innovations, SkyWater Technology, Sleepiz, SmartShape Design, Smiths Medical, Sofie Biosciences, Solis Mammography, SomaLogic, SomaServe, Sona Nanotech, Sonic Healthcare, SonoScape Medical, SonoThera, Sonrai Analytics, SOPHiA Genetics, Soricimed Biopharma, Sorrento Therapeutics, SOTERIA Precision Medicine Foundation, SourceBio International, Source Molecular, Spectrohm, Spectrum Solutions, SpeeDx, Spesana, Spixia Biotechnology, SQI Diagnostics, SRI International, SST Group, St. Jude Children's Research Hospital, Standard BioTools, Stanford University, Stanford University School of Medicine, Starpharma, Statera Biopharma, Stella Diagnostics, Stellar Technologies, Stellenbosch University, StemoniX, Stereotaxis, St Georges University of London, Stockholm University, Stone Diagnostics, Stony Brook University, Storm ID, Strados Labs, Stratasys, STRATIFYER Molecular Pathology, Streck Laboratories, Subtle Medical, Sumaya Biotech, Sunnybrook Research Institute, Surfacide, Susan G. Komen for the Cure, Swift Biosciences, Swiss Institute of Bioinformatics (SIB), Swixx Biopharma, SymphonyAI, Synaptive Medical, Synexa Life Sciences, Synopic, SyntheticMR, Sysmex, Sysmex Inostics, T-Cure Bioscience, T2 Biosystems, Taisho Pharmaceutical, Takara Bio USA, Take2, Takeda Pharmaceutical, Tampere University Hospital, Targos, Tasly Pharmaceuticals, Tauriga Sciences, Taysha Gene Therapies, Tecan, Techcyte, Technogenetics, Tel Aviv University, TeleMammography Specialists, Telix Pharmaceuticals, Telo Genomics, Tempus, TeraRecon, Tesis Biosciences, The Binding Site, The Native Antigen Company, The Parker Institute For Cancer Immunotherapy, Theradiag, Theragnostics, Theralink Technologies, TheraPanacea, Therapixel, Therma Bright, Thermo Fisher Scientific, The Technical University Of Munich, ThinkCyte, ThinkGenetic, Thomas Jefferson University, Three Lakes Foundation, Tissue Analytics, TMM Software, Todos Medical, Tokai University, Tolo Biotech, Topcon, Toray, Tor Vergata University Hospital, Total Brain, Total Testing Solutions, Toyohashi University of Technology, Toyota Tsusho, TPMENA, Transcenta, TransCode Therapeutics, Translational Research Institute for Space Health, TransMIT, Travera, Triage Technologies, Tridiuum, Tried & Tested, Trinity Biotech, TriSalus Life Sciences, TruDiagnostic, True Diagnostics, TruGenomix, TScan Therapeutics, TTP Group, Tulane University, TumorGen, Turner Imaging Systems, Twist Bioscience, Tymora Analytical Operations, U-Diagnostics, U.K. Department for International Development, Ubiquitome, UgenTec, UK Biobank, UK Government, Ulisse Biomed, Ultivue, UltraSight, Ultromics, Uman Diagnostics, Unilabs, UniQure, Uni Targeting Research, United Imaging Healthcare, Universal DX, University College London, University Gastroenterology, University Health Network, University Hospital Bispebjerg, University Hospital Bonn, University of Amsterdam, University of Antwerp, University of Arkansas, University of Augsburg, University of Barcelona, University of Birmingham, University of Bonn, University of Buffalo, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of Chicago, University of Edinburgh, University of Florida, University of Glasgow, University of Heidelberg, University of Hong Kong, University of Houston, University of Illinois, University of Lausanne, University of Leeds, University of Leuven, University of Liverpool, University of Manchester, University of Maryland, Baltimore County, University of Maryland Baltimore, University of Massachusetts Medical School, University of Miami, University of Michigan, University of Milano-Bicocca, University of Newcastle, University of New Mexico, University of North Carolina, University of Ottawa, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Queensland, University of Rennes, University of Sheffield, University of Southampton, University of South Carolina, University of Surrey, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of Tubingen, University of Utah, University of Virginia, University of Washington, University of Wollongong, UPMC, Urology Centers of Alabama, Urology of St Louis, Urology San Antonio, UroPartners, UroViu, Us2.ai, US Air Force, USARAD, US Army Medical Research and Material Command, US Government, US Oncology, Usono, US Radiology Specialists, Vanderbilt University, Varian Medical Systems, Vault Health, Vayyar Imaging, Vect-Horus, Vela Diagnostics, Velox Biosystems, Velsera, Ventus Therapeutics, Veracyte, Veravas, Verici DX, Verily, VeriSIM Life, Veritas, Verogen, Versea Ophthalmics, VIB, Victoria University, Vida Diagnostics, Vidence, ViennaLab Diagnostics, Viewpoint Molecular Targeting, Vincere Cancer Center, VIPUN Medical, ViraCor Laboratories, Viravaxx, Virex Health, Virgo Surgical Video Solutions, Virusight Diagnostics, Visage Imaging, Visby Medical, Visikol, VisionQuest Biomedical, Visiopharm, VistaPath, VisualDx, VitalHub, Vithas Group, Vivera Pharmaceuticals, VolitionRX, Volpara Solutions, Volv Global, VOTIS Subdermal Imaging Technologies, VoxNeuro, VUNO, VyGen-Bio, Vyripharm, WakeMed Health & Hospitals, Wallace H. Coulter Foundation, Waseda University, Washington University in St Louis, Watchmaker Genomics, WAVE Life Sciences, Wayne State University, Weihai Weigao Medical Devices, Weill Cornell Medical College, Weizmann Institute, Wellcome Trust, WellDoc, WellDyne, Wellmarker Bio, Werfen Group, West German Study Group, Whiterabbit, Whitman-Walker Institute, Windber Research Institute, W L Gore, Woom, WuXi Biologics, Wyss Institute, X4 Pharmaceuticals, XCR Diagnostics, Xencor, Xinhua Healthcare Industry, Xpedite Diagnostics, XPhyto Therapeutics, XPRIZE Pandemic Alliance, XtalPi, Xylonix, Y2X Life Sciences, Yale School of Medicine, Yale University, Yantai Dongcheng Biochemicals, Yemaachi Biotech, Yesse Technologies, Yitu Medical, Yi Xin Zhen Duan Jishu, Young Blood Institute, ZAI Laboratory, Zealand University Hospital, Zebra Medical Vision, Zenyaku Kogyo, ZEPHYRx, Zepp Health, ZeptoMetrix, Zimmer Biomet, Zoetis, Zora Biosciences, zPREDICTA, Zylox Tonbridge Medical Technology Co, Ltd, Zymo Research

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.